Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Kiromic BioPharma, Inc. (KRBP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.2614-0.0026 (-0.98%)
At close: 03:35PM EST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
0
Operating Expense
34,428
25,306
19,197
3,705
3,183
Operating Income
-34,428
-25,306
-19,197
-3,705
-3,183
Net Non Operating Interest Income Expense
-12.8
-12.2
-3.3
-22.5
-633.1
Other Income Expense
-3,858
-270.8
-
-
-
Pretax Income
-38,298
-25,589
-19,200
-3,728
-3,816
Tax Provision
-
-
-
0
0
Net Income Common Stockholders
-38,643
-25,811
-19,913
-3,728
-3,816
Diluted NI Available to Com Stockholders
-38,643
-25,811
-19,913
-3,728
-3,816
Basic EPS
-
-2.26
-4.42
-1.06
-1.08
Diluted EPS
-
-2.26
-4.42
-1.06
-1.08
Basic Average Shares
-
11,417
4,506
3,533
3,533
Diluted Average Shares
-
11,417
4,506
3,533
3,533
Total Operating Income as Reported
-34,858
-25,736
-19,197
-3,705
-3,183
Total Expenses
34,428
25,306
19,197
3,705
3,183
Net Income from Continuing & Discontinued Operation
-38,298
-25,589
-19,200
-3,728
-3,816
Normalized Income
-34,405
-25,264
-19,200
-3,728
-3,816
Interest Expense
12.8
12.2
3.3
22.5
633.1
Net Interest Income
-12.8
-12.2
-3.3
-22.5
-633.1
EBIT
-38,285
-25,576
-19,197
-3,705
-3,183
EBITDA
-37,031
-
-
-
-
Reconciled Depreciation
1,255
469.8
200
87.5
80.9
Net Income from Continuing Operation Net Minority Interest
-38,298
-25,589
-19,200
-3,728
-3,816
Total Unusual Items Excluding Goodwill
-3,893
-324.2
-
-
-
Total Unusual Items
-3,893
-324.2
-
-
-
Normalized EBITDA
-33,138
-24,782
-18,997
-3,618
-3,102
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement